Global regulators, industry leaders, scientists, and patient advocates set near-term commitments on early interception, trial modernization, and patient-first evidence. WASHINGTON, Sept. 11, 2025 ...

TUCSON, Ariz., September 4, 2025 —Critical Path Institute® (C-Path) announced today that its Translational Therapeutics Accelerator (TRxA) program has completed a record year of funding and mentorship ...

Critical Path Institute's (C-Path) Translational Therapeutics Accelerator (TRxA) announced today a new research grant awarded to Daniela C. Zarnescu, Ph.D., Professor of Cellular and Molecular ...